What is Jentadueto XR?
Jentadueto XR is an extended-release (XR) combination medicine used in type 2 diabetes. It contains linagliptin plus metformin in an extended-release formulation.
What conditions is it used for?
Like other metformin-based regimens and DPP-4 inhibitor combinations, Jentadueto XR is used to help improve blood sugar control in adults with type 2 diabetes (usually when diabetes is not well controlled with diet, exercise, or other therapies).
How does it work (linagliptin + metformin XR)?
Jentadueto XR combines two glucose-lowering mechanisms:
- Metformin (XR) lowers glucose production by the liver and improves insulin sensitivity.
- Linagliptin helps increase incretin activity, which increases insulin release and decreases glucagon in a glucose-dependent way.
How is it different from regular Jentadueto?
“XR” means the tablets are formulated for extended release, which typically changes how the dose is absorbed compared with the non-XR version (regular Jentadueto). The specific dosing schedule is determined by the prescribing clinician and the product strength.
What are common patient questions about Jentadueto XR?
Patients often ask about:
- Starting dose and titration (metformin is commonly adjusted to reduce GI side effects).
- Side effects, especially those associated with metformin (such as nausea, diarrhea) and class-related effects for DPP-4 inhibitors.
- How to take it (generally at the same time each day, and with attention to meals per the label).
Where to check drug-specific details (label, dosing, and coverage)?
For up-to-date product and market information such as patent/exclusivity tracking, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/
Sources: None provided in the prompt.